Pharmaceutical Industry Medical Communications Departments: Regulatory and Legal Perils and Pitfalls-Reference-Cited by-同舟云学术

Pharmaceutical Industry Medical Communications Departments: Regulatory and Legal Perils and Pitfalls

Published:2000-10 Issue:4 Volume:34 Page:1009-1015
ISSN:0092-8615
Container-title:Drug Information Journal
language:en
Short-container-title:Drug Information J

Author:

Salter Fred J.,Kramer Paul F.,Palmer-Shevlin Nancy L.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Public Health, Environmental and Occupational Health,Drug guides,Pharmacology (nursing)

Link

http://link.springer.com/content/pdf/10.1177/009286150003400403.pdf

Reference10 articles.

1. Anonymous. Drug information. JAMA. 1971;217:201.

2. Kessler DA, Pines WL. The federal regulation of prescription drug advertising and promotion. JAMA. 1990;264:2409–2415.

3. Taylor MR. “Drug regulation, off-label uses and CME-Reconciling competing values,” Food and Drug Law Institute Seminar on Drug Advertising and Promotion, Arlington, VA, February 26, 1992.

4. FDA Public Hearing—Direct-to-Consumer Promotion; October 18, 1995. http://www.fda.gov/cder/ddmac/DTCPANEL7.HTM.

5. Anonymous. Guidance for Industry-Industry-Supported Scientific and Educational Activities. Federal Register. 1997(Dec. 3);62(232):64093–64100.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Medical Information Responses to Unsolicited Health Care Worker Inquiries Submitted via Sales Representatives or Customers Directly;Therapeutic Innovation & Regulatory Science;2014-03

2. Development of a Web-Based Compliance Metrics Reporting Dashboard (CMR©) for Medical Information Inquiries;Drug Information Journal;2012-11

3. Adverse-drug-event data provided by pharmaceutical companies;American Journal of Health-System Pharmacy;2008-06-01

4. Product Launch and the Strategies, Processes, and Operations of Medical Affairs to Support Start-Up Companies;Drug Information Journal;2007-11

5. Medical Affairs and Professional Services;Drug and Biological Development;2007